Although obesity is a risk factor for a number of cancer types and can influence cancer treatment outcomes, obese patients are underrepresented in clinical trials, according to new research. In 2014, kinds of cancer associated with being overweight or obese represented about 40 percent of all cancers diagnosed in the United States. But a new… Continue reading Obese People Underrepresented in Clinical Trials